{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:07:33Z","timestamp":1794344853727,"version":"4.9.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7724","license":[{"start":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T00:00:00Z","timestamp":1537920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T00:00:00Z","timestamp":1537920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2018,9,27]]},"DOI":"10.1038\/s41586-018-0531-2","type":"journal-article","created":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T11:42:51Z","timestamp":1537357371000},"page":"479-484","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":544,"title":["Combination therapy with anti-HIV-1 antibodies maintains viral suppression"],"prefix":"10.1038","volume":"561","author":[{"given":"Pilar","family":"Mendoza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Gruell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy A.","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison L.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Millard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago Y.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio C. C.","family":"Lorenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda Z.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"K\u00fcmmerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Karagounis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Lan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Handl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Unson-O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshni","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Ruping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Schlotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggi","family":"Witmer-Pack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Shimeliovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonore","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly E.","family":"Seaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Anthony P.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"Bjorkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia D.","family":"Tomaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy M.","family":"Gulick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"F\u00e4tkenheuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Seaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Caskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel C.","family":"Nussenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,26]]},"reference":[{"key":"531_CR1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.chom.2016.02.012","volume":"19","author":"G Doitsh","year":"2016","unstructured":"Doitsh, G. & Greene, W. C. Dissecting how CD4 T cells are lost during HIV infection. Cell Host Microbe 19, 280\u2013291 (2016).","journal-title":"Cell Host Microbe"},{"key":"531_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrmicro.2015.5","volume":"14","author":"MJ Churchill","year":"2016","unstructured":"Churchill, M. J., Deeks, S. G., Margolis, D. M., Siliciano, R. F. & Swanstrom, R. HIV reservoirs: what, where and how to target them. Nat. Rev. Microbiol. 14, 55\u201360 (2016).","journal-title":"Nat. Rev. Microbiol."},{"key":"531_CR3","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature21435","volume":"543","author":"Y Nishimura","year":"2017","unstructured":"Nishimura, Y. et al. Early antibody therapy can induce long-lasting immunity to SHIV. Nature 543, 559\u2013563 (2017).","journal-title":"Nature"},{"key":"531_CR4","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41591-018-0001-2","volume":"24","author":"R Gautam","year":"2018","unstructured":"Gautam, R. et al. A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infection. Nat. Med. 24, 610\u2013616 (2018).","journal-title":"Nat. Med."},{"key":"531_CR5","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1126\/science.aaf0972","volume":"352","author":"T Schoofs","year":"2016","unstructured":"Schoofs, T. et al. HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1. Science 352, 997\u20131001 (2016).","journal-title":"Science"},{"key":"531_CR6","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nature14411","volume":"522","author":"M Caskey","year":"2015","unstructured":"Caskey, M. et al. Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117. Nature 522, 487\u2013491 (2015).","journal-title":"Nature"},{"key":"531_CR7","doi-asserted-by":"publisher","first-page":"319ra206","DOI":"10.1126\/scitranslmed.aad5752","volume":"7","author":"RM Lynch","year":"2015","unstructured":"Lynch, R. M. et al. Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection. Sci. Transl. Med. 7, 319ra206 (2015).","journal-title":"Sci. Transl. Med."},{"key":"531_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nm.4268","volume":"23","author":"M Caskey","year":"2017","unstructured":"Caskey, M. et al. Antibody 10-1074 suppresses viremia in HIV-1-infected individuals. Nat. Med. 23, 185\u2013191 (2017).","journal-title":"Nat. Med."},{"key":"531_CR9","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nature18929","volume":"535","author":"JF Scheid","year":"2016","unstructured":"Scheid, J. F. et al. HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption. Nature 535, 556\u2013560 (2016).","journal-title":"Nature"},{"key":"531_CR10","first-page":"343","volume":"30","author":"JZ Li","year":"2016","unstructured":"Li, J. Z. et al. The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption. AIDS 30, 343\u2013353 (2016).","journal-title":"AIDS"},{"key":"531_CR11","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1056\/NEJMoa1608243","volume":"375","author":"KJ Bar","year":"2016","unstructured":"Bar, K. J. et al. Effect of HIV antibody VRC01 on viral rebound after treatment interruption. N. Engl. J. Med. 375, 2037\u20132050 (2016).","journal-title":"N. Engl. J. Med."},{"key":"531_CR12","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1084\/jem.20132494","volume":"211","author":"M Shingai","year":"2014","unstructured":"Shingai, M. et al. Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques. J. Exp. Med. 211, 2061\u20132074 (2014).","journal-title":"J. Exp. Med."},{"key":"531_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature17677","volume":"533","author":"R Gautam","year":"2016","unstructured":"Gautam, R. et al. A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges. Nature 533, 105\u2013109 (2016).","journal-title":"Nature"},{"key":"531_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature11604","volume":"492","author":"F Klein","year":"2012","unstructured":"Klein, F. et al. HIV therapy by a combination of broadly neutralizing antibodies in humanized mice. Nature 492, 118\u2013122 (2012).","journal-title":"Nature"},{"key":"531_CR15","doi-asserted-by":"publisher","first-page":"16538","DOI":"10.1073\/pnas.1315295110","volume":"110","author":"JA Horwitz","year":"2013","unstructured":"Horwitz, J. A. et al. HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice. Proc. Natl Acad. Sci. USA 110, 16538\u201316543 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"531_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nature12746","volume":"503","author":"M Shingai","year":"2013","unstructured":"Shingai, M. et al. Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia. Nature 503, 277\u2013280 (2013).","journal-title":"Nature"},{"key":"531_CR17","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nm1244","volume":"11","author":"A Trkola","year":"2005","unstructured":"Trkola, A. et al. Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies. Nat. Med. 11, 615\u2013622 (2005).","journal-title":"Nat. Med."},{"key":"531_CR18","doi-asserted-by":"publisher","first-page":"11016","DOI":"10.1128\/JVI.01340-07","volume":"81","author":"S Mehandru","year":"2007","unstructured":"Mehandru, S. et al. Adjunctive passive immunotherapy in human immunodeficiency virus type 1-infected individuals treated with antiviral therapy during acute and early infection. J. Virol. 81, 11016\u201311031 (2007).","journal-title":"J. Virol."},{"key":"531_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jim.2013.11.022","volume":"409","author":"M Sarzotti-Kelsoe","year":"2014","unstructured":"Sarzotti-Kelsoe, M. et al. Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1. J. Immunol. Methods 409, 131\u2013146 (2014).","journal-title":"J. Immunol. Methods"},{"issue":"9","key":"531_CR20","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1084\/jem.20180936","volume":"215","author":"Yehuda Z. Cohen","year":"2018","unstructured":"Cohen, Y. Z. et al. Relationship between latent and rebound viruses in a clinical trial of anti\u2013HIV-1 antibody 3BNC117. J. Exp. Med. 215, https:\/\/doi.org\/10.1084\/jem.20180936 (2018).","journal-title":"The Journal of Experimental Medicine"},{"key":"531_CR21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/374124b0","volume":"374","author":"DL Robertson","year":"1995","unstructured":"Robertson, D. L., Sharp, P. M., McCutchan, F. E. & Hahn, B. H. Recombination in HIV-1. Nature 374, 124\u2013126 (1995).","journal-title":"Nature"},{"key":"531_CR22","doi-asserted-by":"publisher","first-page":"E1126","DOI":"10.1073\/pnas.1414926112","volume":"112","author":"MK Rothenberger","year":"2015","unstructured":"Rothenberger, M. K. et al. Large number of rebounding\/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption. Proc. Natl Acad. Sci. USA 112, E1126\u2013E1134 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"531_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004010","volume":"10","author":"MF Kearney","year":"2014","unstructured":"Kearney, M. F. et al. Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy. PLoS Pathog. 10, e1004010 (2014).","journal-title":"PLoS Pathog."},{"key":"531_CR24","doi-asserted-by":"publisher","first-page":"E7908","DOI":"10.1073\/pnas.1617789113","volume":"113","author":"JC Lorenzi","year":"2016","unstructured":"Lorenzi, J. C. et al. Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA. Proc. Natl Acad. Sci. USA 113, E7908\u2013E7916 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"531_CR25","doi-asserted-by":"publisher","first-page":"E2575","DOI":"10.1073\/pnas.1720665115","volume":"115","author":"Z Wang","year":"2018","unstructured":"Wang, Z. et al. Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane. Proc. Natl Acad. Sci. USA 115, E2575\u2013E2584 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"531_CR26","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1084\/jem.20170193","volume":"214","author":"NN Hosmane","year":"2017","unstructured":"Hosmane, N. N. et al. Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: potential role in latent reservoir dynamics. J. Exp. Med. 214, 959\u2013972 (2017).","journal-title":"J. Exp. Med."},{"key":"531_CR27","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/infdis\/jiv218","volume":"212","author":"AM Crooks","year":"2015","unstructured":"Crooks, A. M. et al. Precise quantitation of the latent HIV-1 reservoir: implications for eradication strategies. J. Infect. Dis. 212, 1361\u20131365 (2015).","journal-title":"J. Infect. Dis."},{"key":"531_CR28","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S1074-7613(00)80043-6","volume":"10","author":"P Poignard","year":"1999","unstructured":"Poignard, P. et al. Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo. Immunity 10, 431\u2013438 (1999).","journal-title":"Immunity"},{"key":"531_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jim.2008.11.012","volume":"343","author":"JF Scheid","year":"2009","unstructured":"Scheid, J. F. et al. A method for identification of HIV gp140 binding memory B cells in human blood. J. Immunol. Methods 343, 65\u201367 (2009).","journal-title":"J. Immunol. Methods"},{"key":"531_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1084\/jem.20161765","volume":"214","author":"A Escolano","year":"2017","unstructured":"Escolano, A., Dosenovic, P. & Nussenzweig, M. C. Progress toward active or passive HIV-1 vaccination. J. Exp. Med. 214, 3\u201316 (2017).","journal-title":"J. Exp. Med."},{"key":"531_CR31","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.immuni.2018.04.029","volume":"48","author":"PD Kwong","year":"2018","unstructured":"Kwong, P. D. & Mascola, J. R. HIV-1 vaccines based on antibody identification, B Cell ontogeny, and epitope structure. Immunity 48, 855\u2013871 (2018).","journal-title":"Immunity"},{"key":"531_CR32","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1126\/science.aaf1279","volume":"352","author":"CL Lu","year":"2016","unstructured":"Lu, C. L. et al. Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo. Science 352, 1001\u20131004 (2016).","journal-title":"Science"},{"key":"531_CR33","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nri3478","volume":"13","author":"BD Walker","year":"2013","unstructured":"Walker, B. D. & Yu, X. G. Unravelling the mechanisms of durable control of HIV-1. Nat. Rev. Immunol. 13, 487\u2013498 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"531_CR34","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s41591-018-0026-6","volume":"24","author":"DJ Colby","year":"2018","unstructured":"Colby, D. J. et al. Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection. Nat. Med. 24, 923\u2013926 (2018).","journal-title":"Nat. Med."},{"key":"531_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003211","volume":"9","author":"A S\u00e1ez-Ciri\u00f3n","year":"2013","unstructured":"S\u00e1ez-Ciri\u00f3n, A. et al. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog. 9, e1003211 (2013).","journal-title":"PLoS Pathog."},{"key":"531_CR36","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan8848","volume":"9","author":"MC Sneller","year":"2017","unstructured":"Sneller, M. C. et al. A randomized controlled safety\/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection. Sci. Transl. Med. 9, eaan8848 (2017).","journal-title":"Sci. Transl. Med."},{"key":"531_CR37","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/QAI.0000000000001220","volume":"74","author":"S Fidler","year":"2017","unstructured":"Fidler, S. et al. Virological blips and predictors of post treatment viral control after stopping ART started in primary HIV infection. J. Acquir. Immune Defic. Syndr. 74, 126\u2013133 (2017).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"531_CR38","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/QAD.0000000000001382","volume":"31","author":"GE Martin","year":"2017","unstructured":"Martin, G. E. et al. Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection. AIDS 31, 477\u2013484 (2017).","journal-title":"AIDS"},{"key":"531_CR39","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41591-018-0017-7","volume":"24","author":"LB Cohn","year":"2018","unstructured":"Cohn, L. B. et al. Clonal CD4+ T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation. Nat. Med. 24, 604\u2013609 (2018).","journal-title":"Nat. Med."},{"key":"531_CR40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1126\/science.1254194","volume":"345","author":"F Maldarelli","year":"2014","unstructured":"Maldarelli, F. et al. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells. Science 345, 179\u2013183 (2014).","journal-title":"Science"},{"key":"531_CR41","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1126\/science.1256304","volume":"345","author":"TA Wagner","year":"2014","unstructured":"Wagner, T. A. et al. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection. Science 345, 570\u2013573 (2014).","journal-title":"Science"},{"key":"531_CR42","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.cell.2015.01.020","volume":"160","author":"LB Cohn","year":"2015","unstructured":"Cohn, L. B. et al. HIV-1 integration landscape during latent and active infection. Cell 160, 420\u2013432 (2015).","journal-title":"Cell"},{"key":"531_CR43","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.cell.2014.07.043","volume":"158","author":"A Halper-Stromberg","year":"2014","unstructured":"Halper-Stromberg, A. et al. Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice. Cell 158, 989\u2013999 (2014).","journal-title":"Cell"},{"key":"531_CR44","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nature13612","volume":"514","author":"SY Ko","year":"2014","unstructured":"Ko, S. Y. et al. Enhanced neonatal Fc receptor function improves protection against primate SHIV infection. Nature 514, 642\u2013645 (2014).","journal-title":"Nature"},{"key":"531_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002493","volume":"15","author":"MR Gaudinski","year":"2018","unstructured":"Gaudinski, M. R. et al. Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: a phase 1 open-label clinical trial in healthy adults. PLoS Med. 15, e1002493 (2018).","journal-title":"PLoS Med."},{"key":"531_CR46","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1128\/JVI.02660-07","volume":"82","author":"JF Salazar-Gonzalez","year":"2008","unstructured":"Salazar-Gonzalez, J. F. et al. Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J. Virol. 82, 3952\u20133970 (2008).","journal-title":"J. Virol."},{"key":"531_CR47","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jviromet.2007.02.015","volume":"143","author":"JL Kirchherr","year":"2007","unstructured":"Kirchherr, J. L. et al. High throughput functional analysis of HIV-1 env genes without cloning. J. Virol. Methods 143, 104\u2013111 (2007).","journal-title":"J. Virol. Methods"},{"key":"531_CR48","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1093\/bioinformatics\/btm404","volume":"23","author":"MA Larkin","year":"2007","unstructured":"Larkin, M. A. et al. Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947\u20132948 (2007).","journal-title":"Bioinformatics"},{"key":"531_CR49","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/sysbio\/syq010","volume":"59","author":"S Guindon","year":"2010","unstructured":"Guindon, S. et al. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst. Biol. 59, 307\u2013321 (2010).","journal-title":"Syst. Biol."},{"key":"531_CR50","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1093\/bioinformatics\/btu033","volume":"30","author":"A Stamatakis","year":"2014","unstructured":"Stamatakis, A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 30, 1312\u20131313 (2014).","journal-title":"Bioinformatics"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-018-0531-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-018-0531-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-018-0531-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T13:08:47Z","timestamp":1732712927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-018-0531-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,26]]},"references-count":50,"journal-issue":{"issue":"7724","published-print":{"date-parts":[[2018,9,27]]}},"alternative-id":["531"],"URL":"https:\/\/doi.org\/10.1038\/s41586-018-0531-2","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,26]]},"assertion":[{"value":"6 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":": There are patents on 3BNC117 (PTC\/US2012\/038400) and 10-1074 (PTC\/US2013\/065696) that list M.C.N. as an inventor.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}